AUTOLUS THERAPEUTICS PLC (AUTL) Fundamental Analysis & Valuation

NASDAQ:AUTL • US05280R1005

Current stock price

1.41 USD
-0.07 (-4.73%)
At close:
1.43 USD
+0.02 (+1.42%)
After Hours:

This AUTL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. AUTL Profitability Analysis

1.1 Basic Checks

  • In the past year AUTL has reported negative net income.
  • AUTL had a negative operating cash flow in the past year.
  • In the past 5 years AUTL always reported negative net income.
  • In the past 5 years AUTL always reported negative operating cash flow.
AUTL Yearly Net Income VS EBIT VS OCF VS FCFAUTL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100M -200M -300M

1.2 Ratios

  • With a Return On Assets value of -48.81%, AUTL perfoms like the industry average, outperforming 46.99% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -161.42%, AUTL is doing worse than 66.80% of the companies in the same industry.
Industry RankSector Rank
ROA -48.81%
ROE -161.42%
ROIC N/A
ROA(3y)-44.17%
ROA(5y)-39.58%
ROE(3y)-133.33%
ROE(5y)-99.03%
ROIC(3y)N/A
ROIC(5y)N/A
AUTL Yearly ROA, ROE, ROICAUTL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150

1.3 Margins

  • AUTL does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AUTL Yearly Profit, Operating, Gross MarginsAUTL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -2K -4K -6K -8K -10K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. AUTL Health Analysis

2.1 Basic Checks

  • AUTL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, AUTL has a worse debt to assets ratio.
AUTL Yearly Shares OutstandingAUTL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M
AUTL Yearly Total Debt VS Total AssetsAUTL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • Based on the Altman-Z score of -3.37, we must say that AUTL is in the distress zone and has some risk of bankruptcy.
  • AUTL's Altman-Z score of -3.37 is in line compared to the rest of the industry. AUTL outperforms 44.66% of its industry peers.
  • A Debt/Equity ratio of 1.52 is on the high side and indicates that AUTL has dependencies on debt financing.
  • With a Debt to Equity ratio value of 1.52, AUTL is not doing good in the industry: 79.22% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.52
Debt/FCF N/A
Altman-Z -3.37
ROIC/WACCN/A
WACC7.14%
AUTL Yearly LT Debt VS Equity VS FCFAUTL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M

2.3 Liquidity

  • AUTL has a Current Ratio of 5.94. This indicates that AUTL is financially healthy and has no problem in meeting its short term obligations.
  • AUTL has a Current ratio of 5.94. This is in the better half of the industry: AUTL outperforms 61.75% of its industry peers.
  • AUTL has a Quick Ratio of 5.48. This indicates that AUTL is financially healthy and has no problem in meeting its short term obligations.
  • AUTL's Quick ratio of 5.48 is in line compared to the rest of the industry. AUTL outperforms 58.64% of its industry peers.
Industry RankSector Rank
Current Ratio 5.94
Quick Ratio 5.48
AUTL Yearly Current Assets VS Current LiabilitesAUTL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. AUTL Growth Analysis

3.1 Past

  • The earnings per share for AUTL have decreased strongly by -24.14% in the last year.
  • Looking at the last year, AUTL shows a very strong growth in Revenue. The Revenue has grown by 644.94%.
  • AUTL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 112.99% yearly.
EPS 1Y (TTM)-24.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-240%
Revenue 1Y (TTM)644.94%
Revenue growth 3Y128.01%
Revenue growth 5Y112.99%
Sales Q2Q%83655.17%

3.2 Future

  • Based on estimates for the next years, AUTL will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.96% on average per year.
  • Based on estimates for the next years, AUTL will show a very strong growth in Revenue. The Revenue will grow by 57.16% on average per year.
EPS Next Y14.06%
EPS Next 2Y14.36%
EPS Next 3Y14.16%
EPS Next 5Y17.96%
Revenue Next Year74.54%
Revenue Next 2Y63.92%
Revenue Next 3Y61.38%
Revenue Next 5Y57.16%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
AUTL Yearly Revenue VS EstimatesAUTL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
AUTL Yearly EPS VS EstimatesAUTL Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 1 -1 -2

More info and screens

Find the best growth stocksShow best growing peers

0

4. AUTL Valuation Analysis

4.1 Price/Earnings Ratio

  • AUTL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year AUTL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AUTL Price Earnings VS Forward Price EarningsAUTL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AUTL Per share dataAUTL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

  • AUTL's earnings are expected to grow with 14.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.36%
EPS Next 3Y14.16%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AUTL Dividend Analysis

5.1 Amount

  • No dividends for AUTL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AUTL Fundamentals: All Metrics, Ratios and Statistics

AUTOLUS THERAPEUTICS PLC

NASDAQ:AUTL (4/29/2026, 8:00:01 PM)

After market: 1.43 +0.02 (+1.42%)

1.41

-0.07 (-4.73%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)03-27
Earnings (Next)05-06
Inst Owners69.47%
Inst Owner Change0.01%
Ins Owners0.01%
Ins Owner Change0%
Market Cap375.26M
Revenue(TTM)75.39M
Net Income(TTM)-287.53M
Analysts85.56
Price Target8.71 (517.73%)
Short Float %6.28%
Short Ratio8.57
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-27.75%
Min EPS beat(2)-30.31%
Max EPS beat(2)-25.2%
EPS beat(4)1
Avg EPS beat(4)-8.08%
Min EPS beat(4)-30.31%
Max EPS beat(4)25.13%
EPS beat(8)2
Avg EPS beat(8)-45.08%
EPS beat(12)3
Avg EPS beat(12)-36.31%
EPS beat(16)6
Avg EPS beat(16)-25.59%
Revenue beat(2)0
Avg Revenue beat(2)-2.73%
Min Revenue beat(2)-2.73%
Max Revenue beat(2)-2.73%
Revenue beat(4)2
Avg Revenue beat(4)95%
Min Revenue beat(4)-2.73%
Max Revenue beat(4)326.5%
Revenue beat(8)2
Avg Revenue beat(8)2.56%
Revenue beat(12)3
Avg Revenue beat(12)5.7%
Revenue beat(16)5
Avg Revenue beat(16)97.87%
PT rev (1m)-2.09%
PT rev (3m)-4.83%
EPS NQ rev (1m)-6.29%
EPS NQ rev (3m)-10.14%
EPS NY rev (1m)-6.85%
EPS NY rev (3m)-16.72%
Revenue NQ rev (1m)-4.53%
Revenue NQ rev (3m)-2.86%
Revenue NY rev (1m)-2.91%
Revenue NY rev (3m)-5.73%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.98
P/FCF N/A
P/OCF N/A
P/B 2.11
P/tB 2.37
EV/EBITDA N/A
EPS(TTM)-1.08
EYN/A
EPS(NY)-0.93
Fwd EYN/A
FCF(TTM)-1.17
FCFYN/A
OCF(TTM)-1.07
OCFYN/A
SpS0.28
BVpS0.67
TBVpS0.59
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -48.81%
ROE -161.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-44.17%
ROA(5y)-39.58%
ROE(3y)-133.33%
ROE(5y)-99.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 1.52
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 276.46%
Cap/Sales 35.99%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.94
Quick Ratio 5.48
Altman-Z -3.37
F-Score2
WACC7.14%
ROIC/WACCN/A
Cap/Depr(3y)298.35%
Cap/Depr(5y)229.18%
Cap/Sales(3y)342.35%
Cap/Sales(5y)315.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-240%
EPS Next Y14.06%
EPS Next 2Y14.36%
EPS Next 3Y14.16%
EPS Next 5Y17.96%
Revenue 1Y (TTM)644.94%
Revenue growth 3Y128.01%
Revenue growth 5Y112.99%
Sales Q2Q%83655.17%
Revenue Next Year74.54%
Revenue Next 2Y63.92%
Revenue Next 3Y61.38%
Revenue Next 5Y57.16%
EBIT growth 1Y-12.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year23.88%
EBIT Next 3Y20.88%
EBIT Next 5Y26.98%
FCF growth 1Y-28.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-37.47%
OCF growth 3YN/A
OCF growth 5YN/A

AUTOLUS THERAPEUTICS PLC / AUTL Fundamental Analysis FAQ

What is the fundamental rating for AUTL stock?

ChartMill assigns a fundamental rating of 2 / 10 to AUTL.


What is the valuation status of AUTOLUS THERAPEUTICS PLC (AUTL) stock?

ChartMill assigns a valuation rating of 0 / 10 to AUTOLUS THERAPEUTICS PLC (AUTL). This can be considered as Overvalued.


What is the profitability of AUTL stock?

AUTOLUS THERAPEUTICS PLC (AUTL) has a profitability rating of 0 / 10.


What is the earnings growth outlook for AUTOLUS THERAPEUTICS PLC?

The Earnings per Share (EPS) of AUTOLUS THERAPEUTICS PLC (AUTL) is expected to grow by 14.06% in the next year.